The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., & Riccardi, C. (1991) · Journal of Immunological Methods · doi:10.1016/0022-1759(91)90198-o · Cited by 4,579
Molecular characterization of mitochondrial apoptosis-inducing factor
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Snow, B. E., Brothers, G. M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., et al. (1999) · Nature · doi:10.1038/17135 · Cited by 4,060
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Two CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Self-citationIAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497 · cited 3×
“Unlike the other death ligands CD95 ligand or TNFa, systemic administration of TRAIL does not cause toxicity in mice or nonhuman primates (Walczak and Krammer, 2000; Walczak et al., 1999; Lawrence et al., 2001; Ichikawa et al., 2001; Nagane et al., 2001).”
BackgroundSlee, E. A., Harte, M. T., Kluck, R. M., Wolf, B. B., Casiano, C. A., Newmeyer, D. D., Wang, H.-G., Reed, J. C., Nicholson, D. W., Alnemri, E. S., et al. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.2.281 · Cited by 1,929
The proto-oncogene Bcl-2 and its role in regulating apoptosis
Kroemer, G. (1997) · Nature Medicine · doi:10.1038/nm0697-614 · Cited by 1,739 · cited 5×
“High Bcl-2 expression has been correlated with poor prognosis in some instances and also likely plays a role in chemoresistance (Kroemer, 1997; Hoehner et al., 1995; Fels et al., 2000).”
BackgroundInfluentialInduction of Apoptosis by Cancer Chemotherapy
Kaufmann, S. H., & Earnshaw, W. C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4838 · Cited by 1,266 · cited 3×
“…conditions and has also been implied to mediate therapy-induced cytotoxicity, e.g. in response to cyto- toxic drug treatment, g-irradiation or cytotoxic cytokines (Peter and Krammer, 1998; Schulze-Ostho et al., 1998; Kaufmann and Earnshaw, 2000; Debatin, 1997; Fulda et al., 1997, 1998b).”
BackgroundFLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
Medema, J. P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2794 · Cited by 1,188
Slee, E. A., Adrain, C., & Martin, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008363200 · Cited by 1,115
Apoptosis signaling by death receptors
Schulze‐Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., & Peter, M. E. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540439.x · Cited by 978
Sprick, M. R., Weigand, M. A., Rieser, E., Rauch, C. T., Juo, P., Blenis, J., Krammer, P. H., & Walczak, H. (2000) · Immunity · doi:10.1016/s1074-7613(00)80211-3 · Cited by 794
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
Lawrence, D., Shahrokh, Z., Marsters, S., Achilles, K., Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Schow, P., et al. (2001) · Nature Medicine · doi:10.1038/86397 · Cited by 702
Suzuki, Y., Nakabayashi, Y., & Takahashi, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161506698 · Cited by 654
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 628
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
Ichikawa, K., Liu, W., Zhao, L., Wang, Z., Liu, D., Ohtsuka, T., Zhang, H., Mountz, J. D., Koopman, W. J., Kimberly, R. P., et al. (2001) · Nature Medicine · doi:10.1038/91000 · Cited by 543
Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
Peter, M. E., & Krammer, P. H. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80222-7 · Cited by 498
Wolf, B. B., Schuler, M., Echeverri, F., & Green, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30651 · Cited by 487
The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
Fulda, S., Sieverts, H., Friesen, C., Herr, I., & Debatin, K. (1997) · PubMed · Cited by 482
Self-citationCleavage of Automodified Poly(ADP-ribose) Polymerase during Apoptosis
Germain, M., Affar, E. B., D'Amours, D., Dixit, V. M., Salvesen, G. S., & Poirier, G. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28379 · Cited by 444
Suliman, A., Lam, A., Datta, R., & Srivastava, R. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204282 · Cited by 419
FLICE Is Predominantly Expressed as Two Functionally Active Isoforms, Caspase-8/a and Caspase-8/b
Scaffidi, C., Medema, J. P., Krammer, P. H., & Peter, M. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26953 · Cited by 390
Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis
Hinz, S., Trauzold, A., Boenicke, L., Sandberg, C., Beckmann, S., Bayer, E., Walczak, H., Kalthoff, H., & Ungefroren, H. (2000) · Oncogene · doi:10.1038/sj.onc.1203936 · Cited by 275
Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells.
Fulda, S., Susín, S. A., Kroemer, G., & Debatin, K. (1998) · PubMed · Cited by 261
Self-citationHolcik, M., & Korneluk, R. G. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35080103 · Cited by 251
Fulda, S., Meyer, É., & Debatin, K. (2000) · PubMed · Cited by 237
Self-citationWalczak, H., Bouchon, A., Stahl, H. F., & Krammer, P. H. (2000) · PubMed · Cited by 234
APO2 ligand: a novel lethal weapon against malignant glioma?
Rieger, J., Naumann, U., Glaser, T., Ashkenazi, A., & Weller, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00409-8 · Cited by 189
The potential of TRAIL for cancer chemotherapy
Nagane, M., Huang, H.-J. S., & Cavenee, W. K. (2001) · APOPTOSIS · doi:10.1023/a:1011336726649 · Cited by 161
Sun, S., Yue, P., Zhou, J.-Y., Wang, Y.-H., Kim, H.-R. C., Lotan, R., & Wu, G. S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4218 · Cited by 138
Fulda, S., Scaffidi, C., Pietsch, T., Krammer, P. H., Peter, M. E., & Debatin, K. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400419 · Cited by 131
Self-citationRuiz‐Ruiz, C., Muñoz‐Pinedo, C., & López‐Rivas, A. (2000) · PubMed · Cited by 130
Mitsiades, N., Poulaki, V., Tseleni‐Balafouta, S., Koutras, D. A., & Stamenkovic, I. (2000) · PubMed · Cited by 106
Failure of Bcl‐2 to block cytochrome c redistribution during TRAIL‐induced apoptosis
Keogh, S. A., Walczak, H., Bouchier‐Hayes, L., & Martin, S. J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01375-2 · Cited by 106
Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosis
Rokhlin, O. W., Guseva, N., Taghiyev, A. F., Knudson, C. M., & Cohen, M. B. (2001) · Oncogene · doi:10.1038/sj.onc.1204410 · Cited by 66
Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl‐2 expression
Hoehner, J. C., Hedborg, F., Jernberg‐Wiklund, H., Olsen, L., & Påhlman, S. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620106 · Cited by 64
Bcl-2 Expression in Higher-grade Human Glioma: A Clinical and Experimental Study
Fels, C., Schäfer, C., Hüppe, B., Bahn, H., Heidecke, V., Kramm, C. M., Lautenschläger, C., & Rainov, N. G. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006484801654 · Cited by 62
APOPTOSIS-INDUCED BY TRAIL AND TNF-α IN HUMAN MULTIPLE MYELOMA CELLS IS NOT BLOCKED BY BCL-2
Gazitt, Y., Shaughnessy, P. J., & Montgomery, W. (1999) · Cytokine · doi:10.1006/cyto.1999.0536 · Cited by 60
Cytotoxic Drugs, Programmed Cell Death, and the Immune System: Defining New Roles in an Old Play
Debatin, K. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.11.750 · Cited by 59
Self-citation
Cited by
Apoptosis in cancer: from pathogenesis to treatment
Wong, R. S. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-87 · Cited by 2,836
“For example, Raffo et al showed that the overexpression of Bcl-2 protected prostate cancer cells from apoptosis [36] while Fulda et al reported Bcl-2 overexpression led to inhibition of TRAIL-induced apoptosis in neuroblastoma, glioblastoma and breast carcinoma cells [37].”
BackgroundExtrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312
“Importantly, Smac peptides even enhanced the antitumor activity of TRAIL in vivo in an intracranial malignant glioma xenograft model (Fulda et al., 2002b).”
BackgroundMethodInfluentialSelf-citationPistritto, G., Trisciuoglio, D., Ceci, C., Garufi, A., & D'Orazi, G. (2016) · Aging · doi:10.18632/aging.100934 · Cited by 1,658
The mitochondrial membrane potential (Δψm) in apoptosis; an update
Ly, J. D., Grubb, D. R., & Lawen, A. (2003) · Apoptosis · doi:10.1023/a:1022945107762 · Cited by 1,591
Genetically encoded fluorescent indicator for intracellular hydrogen peroxide
Belousov, V. V., Fradkov, A. F., Lukyanov, K. A., Staroverov, D. B., Shakhbazov, K. S., Terskikh, A. V., & Lukyanov, S. (2006) · Nature Methods · doi:10.1038/nmeth866 · Cited by 1,258
Metadata
- Authors
- Fulda, S., Meyer, E., & Debatin, K.-M.
- Venue
- Oncogene
- Published
- 2002-04-04
- Volume
- 21
- Issue
- 15
- Pages
- 2283-2294
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2320870975
- Cited by
- 394
- References
- 43
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.